Emma Di Carlo
- Immunology top 0.5%
- Immunotherapy and Immune Responses 53
- Immune Cell Function and Interaction 34
- T-cell and B-cell Immunology 21
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 19
- Chemokine receptors and signaling 16
- CAR-T cell therapy research 14
- Cancer Immunotherapy and Biomarkers 14
- Biotechnology top 2%
- Immunology and Allergy top 5%
- Cancer Research top 5%
-
- Virus-based gene therapy research 15
- Co-authors
- Piero MusianiCarlo SorrentinoPier‐Luigi LolliniMario P. ColomboGuido ForniPatrizia NanniAndrea ModestiSilvano Ferrini
- Cited by
- ImmunologyOncologyBiotechnology
- Journals
- The Journal of Immunology (16 papers)International Journal of Cancer (9 papers)Cancer Research (8 papers)
- Partner nations
- ItalyUnited StatesBelgium
In The Last Decade
Emma Di Carlo
125 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 124
- Immunology 4.0k
- Oncology 2.9k
- Biotechnology 329
- Immunology and Allergy 202
- Cancer Research 500
Countries citing papers authored by Emma Di Carlo
This map shows the geographic impact of Emma Di Carlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Di Carlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Di Carlo more than expected).
Fields of papers citing papers by Emma Di Carlo
This network shows the impact of papers produced by Emma Di Carlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Di Carlo. The network helps show where Emma Di Carlo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emma Di Carlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 24 | |
| 2 | 2023 | 11 | |
| 3 | 2018 | 38 | |
| 4 | 2017 | 95 | |
| 5 | 2016 | 32 | |
| 6 | 2010 | 65 | |
| 7 | 2008 | 166 | |
| 8 | 2006 | 17 | |
| 9 | 2004 | 64 | |
| 10 | 2004 | 127 | |
| 11 | 2003 | 23 | |
| 12 | 2003 | 19 | |
| 13 | 2003 | 17 | |
| 14 | 2003 | 53 | |
| 15 | Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. | 2002 | 5 |
| 16 | 2001 | 25 | |
| 17 | Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. | 2001 | 33 |
| 18 | 2001 | 191 | |
| 19 | Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. | 2000 | 72 |
| 20 | 2000 | 308 |
About Emma Di Carlo
Emma Di Carlo is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 125 papers that have together received 6.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (53 papers), Immune Cell Function and Interaction (34 papers), T-cell and B-cell Immunology (21 papers), Cytokine Signaling Pathways and Interactions (19 papers), Chemokine receptors and signaling (16 papers), Virus-based gene therapy research (15 papers), CAR-T cell therapy research (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Immunology (4.0k citations), Oncology (2.9k citations) and Biotechnology (329 citations). Emma Di Carlo has collaborated with scholars based in Italy, United States and Belgium. Frequent co-authors include Piero Musiani, Carlo Sorrentino, Pier‐Luigi Lollini, Mario P. Colombo, Guido Forni, Patrizia Nanni, Andrea Modesti, Silvano Ferrini, Lorena Landuzzi and Carla De Giovanni. Their work appears in journals such as The Journal of Immunology, International Journal of Cancer, Cancer Research, The Journal of Pathology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.